Assignee
EPITAS BIOSCIENCES SHANGHAI CO LTD
CN·0 granted patents·3 pending applications·0 citations·filing 2020–2020
Top patents by PatentIndex Score
3 records- 0139US2022204509A1Pyrimido five-membered heterocyclic compound and use thereof as mutant idh2 inhibitorEPITAS BIOSCIENCES SHANGHAI CO LTD·Filed 2020·Application pending·0 cites
- 0237US2022213070A1Compounds inhibiting tdg activityEPITAS BIOSCIENCES SHANGHAI CO LTD·Filed 2020·Application pending·0 cites
- 0336US2022267309A1Dimeric or polymeric form of mutant idh inhibitorEPITAS BIOSCIENCES SHANGHAI CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EPITAS BIOSCIENCES SHANGHAI CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →